Literature DB >> 18024089

Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment.

Esther Sobanski1, Daniel Brüggemann, Barbara Alm, Sebastian Kern, Alexandra Philipsen, Hannah Schmalzried, Bernd Hesslinger, H Waschkowski, Marcella Rietschel.   

Abstract

BACKGROUND: To date, nearly all research of subtype differences in ADHD has been performed in children and only two studies, with conflicting results, have covered this subject in adults with ADHD.
OBJECTIVE: This study examined subtype differences in the clinical presentation of ADHD-symptoms, related psychopathological features, psychosocial functioning and comorbid psychiatric disorders in adults with ADHD.
METHOD: One hundred and eighteen adults with ADHD, diagnosed according to DSM-IV criteria, and a population based control group underwent diagnostic evaluations with clinical interviews for ADHD, DSM-IV disorders and demographic features. Comparisons were made between ADHD combined type (n=64), predominantly inattentive type (n=30) and predominantly inattentive type, anamnestically combined type (n=24), relative to each other and to a community control group (n=70).
RESULTS: The four groups did not differ in age and gender composition. All ADHD groups had significantly less education, were significantly more often unemployed and reported significantly more lifetime psychiatric comorbidity than controls. In comparison to each other, the three ADHD groups differed mainly in core symptoms and the pattern of comorbid psychiatric disorders, whereas no prominent differences in associated psychopathological features and most of the assessed psychosocial functions could be found. Patients with ADHD combined type and inattentive, anamnestically combined type both presented with significantly more hyperactive symptoms and also showed more impulsive symptoms than those with the predominantly inattentive type. With a similar overall lifetime psychiatric comorbidity in the three groups, patients with ADHD combined type and inattentive, anamnestically combined type suffered significantly more from lifetime substance use disorders than patients with predominantly inattentive type.
CONCLUSION: Our results clearly show impaired psychosocial adjustment and elevated risk for additional psychiatric disorders in adults with all subtypes of ADHD, compared to healthy controls. They provide preliminary evidence that in adult ADHD there might be a subgroup of patients, which is classified as predominantly inattentive subtype according to current diagnostic criteria, but which in its clinical presentation is in between ADHD combined and inattentive type. Further studies are needed to evaluate this finding and to gain a clear picture of its validity.

Entities:  

Mesh:

Year:  2007        PMID: 18024089     DOI: 10.1016/j.eurpsy.2007.09.007

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  27 in total

1.  Attention-deficit/hyperactivity disorder subtypes in adolescents with comorbid substance-use disorder.

Authors:  Leanne Tamm; Bryon Adinoff; Paul A Nakonezny; Theresa Winhusen; Paula Riggs
Journal:  Am J Drug Alcohol Abuse       Date:  2011-08-11       Impact factor: 3.829

2.  Psychiatric comorbidity in treatment-seeking substance use disorder patients with and without attention deficit hyperactivity disorder: results of the IASP study.

Authors:  Katelijne van Emmerik-van Oortmerssen; Geurt van de Glind; Maarten W J Koeter; Steve Allsop; Marc Auriacombe; Csaba Barta; Eli Torild H Bu; Yuliya Burren; Pieter-Jan Carpentier; Susan Carruthers; Miguel Casas; Zsolt Demetrovics; Geert Dom; Stephen V Faraone; Melina Fatseas; Johan Franck; Brian Johnson; Máté Kapitány-Fövény; Sharlene Kaye; Maija Konstenius; Frances R Levin; Franz Moggi; Merete Møller; J Antoni Ramos-Quiroga; Arild Schillinger; Arvid Skutle; Sofie Verspreet; Wim van den Brink; Robert A Schoevers
Journal:  Addiction       Date:  2013-11-20       Impact factor: 6.526

3.  Efficacy of guanfacine extended release in the treatment of combined and inattentive only subtypes of attention-deficit/hyperactivity disorder.

Authors:  Floyd R Sallee; Scott H Kollins; Timothy L Wigal
Journal:  J Child Adolesc Psychopharmacol       Date:  2012-05-21       Impact factor: 2.576

Review 4.  [The health economics of attention deficit hyperactivity disorder in Germany. Part 1: Health care utilization and cost of illness].

Authors:  M Schlander; G-E Trott; O Schwarz
Journal:  Nervenarzt       Date:  2010-03       Impact factor: 1.214

5.  Functioning Assessment Short Test (FAST): validity and reliability in adults with attention-deficit/hyperactivity disorder.

Authors:  Sofía Rotger; Vanesa Richarte; Mariana Nogueira; Montse Corrales; Rosa Bosch; Raquel Vidal; Lidia Marfil; Sergi Valero; Eduard Vieta; José Manuel Goikolea; Imma Torres; Adriane Rosa; María Mur; Miguel Casas; Josep Antoni Ramos-Quiroga
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2014-04-08       Impact factor: 5.270

6.  Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial.

Authors:  E Hoxhaj; C Sadohara; P Borel; R D'Amelio; E Sobanski; H Müller; B Feige; S Matthies; Alexandra Philipsen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2018-01-22       Impact factor: 5.270

7.  The Investigation of Symptoms and Diagnoses of Adult-Attention Deficit/ Hyperactivity Disorder in Women with Iron Deficiency Anemia.

Authors:  Kadir Demirci; Funda Yildirim Baş; Bahriye Arslan; Zeliha Salman; Abdullah Akpinar; Arif Demirdaş
Journal:  Noro Psikiyatr Ars       Date:  2016-03-04       Impact factor: 1.339

Review 8.  [Age and gender aspects of attention-deficit hyperactivity disorder].

Authors:  P Retz-Junginger; E Sobanski; B Alm; W Retz; M Rösler
Journal:  Nervenarzt       Date:  2008-07       Impact factor: 1.214

9.  Association between ADHD drug use and injuries among children and adolescents.

Authors:  Els van den Ban; Patrick Souverein; Willemijn Meijer; Herman van Engeland; Hanna Swaab; Toine Egberts; Eibert Heerdink
Journal:  Eur Child Adolesc Psychiatry       Date:  2013-06-04       Impact factor: 4.785

10.  Developmental psychopathology: Attention Deficit Hyperactivity Disorder (ADHD).

Authors:  Sören Schmidt; Franz Petermann
Journal:  BMC Psychiatry       Date:  2009-09-17       Impact factor: 3.630

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.